Across TCGA pan-cancer cohorts, RNA5SP283 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNA5SP283 data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RNA5SP283 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNA5SP283 expression acts as an unfavorable survival marker, although some lineages such as UCS and UVM show a favorable association.
UCS, UVM, and ACC are the cancer types where RNA5SP283 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.